Jianyou shares: Micafenone for injection was approved by FDA for drug registration.

　　() Announced on the evening of September 29th, the company recently received the approval letters of micafungin for injection, 50mg/ bottle and 100mg/ bottle issued by the US FDA. The indications of drugs are candidemia, acute disseminated candidiasis, candida peritonitis and abscess.

　　Shanghai Electromechanical hired Guo Liping as the chief financial officer.

　　() Announce that Ms. Zheng Yingxia no longer serves as the secretary of the board of directors and the chief financial officer of the company due to job changes; Ms. Guo Liping was hired as the chief financial officer of the company, and at the same time, Ms. Guo Liping performed the duties of secretary of the board of directors of the company on her behalf.

　　Jingye Intelligent was selected as a national "Little Giant" enterprise specializing in novelty.

　　Jingye Intelligent Releases Announcement. Recently, the Ministry of Industry and Information Technology of the People’s Republic of China issued the Notice of the Ministry of Industry and Information Technology on Releasing the List of the Fourth Batch of Specialized and Newly Developed "Little Giant" Enterprises and the First Batch of Specialized and Newly Developed "Little Giant" Enterprises that passed the review (Enterprise Letter [2022] No.191 of the Ministry of Industry and Information Technology), and the company was recognized as the title of the fourth batch of specialized and newly developed "Little Giant" enterprises at the national level, valid for 3 years.

　　Jianyou Co., Ltd. obtained the registration approval of "Micafenone for Injection" from FDA of the United States.

　　Jianyou Co., Ltd. announced that the company had recently received the approval letters for micafungin for injection, 50mg/ bottle and 100mg/ bottle (ANDANo.: 215381) issued by the US Food and Drug Administration ("FDA"). It is reported that the indications of this drug are: treatment of candidemia, acute disseminated candidiasis, candida peritonitis and abscess, esophageal candidiasis, and prevention of candida infection in patients undergoing hematopoietic stem cell transplantation (HSCT).

　　Zhang Lijun, the core technician of Secco Sid, left.

　　Secco Sid announced that Ms. Zhang Lijun, the company’s core technician, recently applied to the company for resignation due to personal reasons, and will no longer hold any position in the company after her resignation.

　　Ms. Zhang Lijun signed the Confidentiality Agreement on Keeping Trade Secrets and Intellectual Property Rights with the company. During her tenure as a co-inventor, all the patents applied for were the results of her duties, and the ownership belonged to the company, which did not involve any rights disputes or potential disputes. Her resignation will not affect the integrity of the company’s patent rights. The work that Ms. Zhang Lijun is responsible for has been handed over, and the company’s production and operation, technology research and development have been promoted in an orderly manner. Ms. Zhang Lijun’s departure will not have a substantial impact on the company’s operating ability, R&D strength and core competitiveness.

　　Jingye Intelligence: Selected as a national "Little Giant" enterprise specializing in specialty and novelty.

　　Jingye Intelligent announced on the evening of September 29th that the company was recognized as the fourth batch of state-level specialized and new "Little Giant" enterprises with a validity period of 3 years.

　　Yangtze Power Company plans to join the Three Gorges Land New Energy to help clean energy development.

　　() Announced that the company, its controlling shareholder, China Three Gorges Corporation Limited ("China Three Gorges Corporation"), its holding subsidiary China Three Gorges New Energy (Group) Co., Ltd. ("Three Gorges Capital") and its wholly-owned subsidiary Yangtze Three Gorges Investment Management Co., Ltd. ("Three Gorges Land New Energy")

　　The land-based new energy of the Three Gorges Project is planned to have a registered capital of 10 billion yuan, with its registered address in Hohhot, Inner Mongolia Autonomous Region, and its business scope is planned to be the investment and development of new energy sources such as wind energy, solar energy, bioenergy, geothermal energy, hydrogen energy and energy storage, and the upstream and downstream of the industrial chain; Power generation business, power transmission business, power supply (distribution) business; Thermal power generation (tentative, the final business scope is subject to industrial and commercial approval). The Three Gorges onshore new energy resources are subscribed by Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment in the form of money, with the corresponding shareholding ratios of 34%, 33%, 16.5% and 16.5% respectively.

　　According to the announcement, the company, Three Gorges Energy, Three Gorges Capital and Three Gorges Investment jointly funded the establishment of the Three Gorges onshore new energy, which is an important embodiment of implementing the national strategy of "peak carbon dioxide emissions, Carbon Neutralization" and assisting the development of clean energy. It is also an important measure to implement the company’s development strategy, which is of great strategic significance for the company to vigorously develop new energy base projects and expand new energy resources in Inner Mongolia, continuously optimize the company’s investment structure, expand new development space and further promote the company’s high-quality sustainable development.

　　Yangtze Power Company plans to join the Three Gorges Land New Energy to help clean energy development.

　　Changjiang Electric Power announced that the company, its controlling shareholder, China Three Gorges Corporation Limited ("China Three Gorges Corporation"), its holding subsidiary, China Three Gorges New Energy (Group) Co., Ltd. ("Three Gorges Capital") and its wholly-owned subsidiary, Yangtze Three Gorges Investment Management Co., Ltd. ("Three Gorges Onshore New Energy") jointly funded the establishment of Inner Mongolia Three Gorges New Energy Investment Co., Ltd.

　　The land-based new energy of the Three Gorges Project is planned to have a registered capital of 10 billion yuan, with its registered address in Hohhot, Inner Mongolia Autonomous Region, and its business scope is planned to be the investment and development of new energy sources such as wind energy, solar energy, bioenergy, geothermal energy, hydrogen energy and energy storage, and the upstream and downstream of the industrial chain; Power generation business, power transmission business, power supply (distribution) business; Thermal power generation (tentative, the final business scope is subject to industrial and commercial approval). The Three Gorges onshore new energy resources are subscribed by Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment in the form of money, with the corresponding shareholding ratios of 34%, 33%, 16.5% and 16.5% respectively.

　　According to the announcement, the company, Three Gorges Energy, Three Gorges Capital and Three Gorges Investment jointly funded the establishment of the Three Gorges onshore new energy, which is an important embodiment of implementing the national strategy of "peak carbon dioxide emissions, Carbon Neutralization" and assisting the development of clean energy. It is also an important measure to implement the company’s development strategy, which is of great strategic significance for the company to vigorously develop new energy base projects and expand new energy resources in Inner Mongolia, continuously optimize the company’s investment structure, expand new development space and further promote the company’s high-quality sustainable development.

　　China Sports Industry plans to acquire 100% equity of Xinyi Yaju to acquire a residential land in Dalian.

　　() Announcement: Dalian Lebainian Real Estate Co., Ltd. (hereinafter referred to as "Dalian Lebainian"), a wholly-owned subsidiary of the company, acquired 100% equity of Dalian Xinyi Yaju Industrial Co., Ltd. (hereinafter referred to as "Xinyi Yaju") held by Xinchuang Yangfan (Dalian) Health Technology Industrial Investment Co., Ltd. through its own funds, and obtained the land use right and subsequent development rights of the "A3 plot" owned by Xinyiya’s residence. The transaction price is 103 million yuan.

　　According to the announcement, Xinyi Yaju has no other real estate and operating assets except the existing two real estate A3 residential land and C1 commercial and financial land. The target of this proposed acquisition is only plot A3, and plot C1 is separated from Xinyi Yaju Company by agreement. A3 residential land is located in Longtou Village, Longtou Street, Lushunkou District, with a parcel area of 40,315.8 square meters. The real estate has other rights, and the right holder is China Huarong Asset Management Co., Ltd. Henan Branch. The right type is general mortgage, with the mortgage area of 40,315.8 square meters and the right value of 90 million yuan.

　　The real controller of Linglong Tire plans to spend 15 million yuan to 20 million yuan to increase its shareholding.

　　() Announce that Wang Xicheng, the actual controller of the company, intends to increase the company’s shares based on the recognition of the confidence and value of the company’s future development and in order to maintain the stability of the stock price and the interests of shareholders. The scale of this increase plan is not less than 15 million yuan and not more than 20 million yuan. There is no price range for this increase, and the period is within 6 months from the date of announcement.

　　Linglong Tire: The actual controller plans to increase its holdings by 15 million yuan to 20 million yuan.

　　Linglong Tire announced that the actual controller of the company plans to increase its holdings by not less than 15 million yuan and not more than 20 million yuan. There is no price range for this increase.

　　The subordinate of Jiangxi Changyun intends to transfer the related assets agreement of Dexing Station to Dexing for trading.

　　() Announcement: In order to meet the needs of the implementation of urban planning and the promotion of urbanization in Dexing City, and to support the development of highway passenger transport business in Dexing City, Dexing Municipal People’s Government plans to relocate Dexing Bus Station, a wholly-owned subsidiary of Shangrao Automobile Transportation Group Co., Ltd. ("Shangrao Automobile Transportation"), and the original lines and vehicles of Dexing Station will be relocated to Nanmen Comprehensive Bus Station (Dexing New Bus Station) located in the service industry cluster.

　　After full consultation, Shangrao Automobile Transportation Dexing Company, Dexing Huaneng Changyun Co., Ltd. and Shangrao Automobile Transportation Group Dexing Zhencun Bus Passenger Transport Co., Ltd. intend to transfer the assets related to Dexing Station to Dexing Transportation Investment Co., Ltd. for 29.24 million yuan.

　　Linglong Tire: The actual controller plans to increase the company’s shares by 15 million yuan to 20 million yuan.

　　Linglong Tire announced on the evening of September 29th that Wang Xicheng, the actual controller of the company, plans to increase the company’s shares by 15-20 million yuan within six months, and there is no price range for this increase.

　　Yuntianhua: Signing the cooperation intention agreement between iron phosphate and Ferrous lithium phosphate project.

　　() Announcement, signing the Agreement of Intention on Cooperation of Iron Phosphate and Ferrous lithium phosphate Project with Huayou Holdings. The two sides intend to promote the construction and operation of the 500,000-ton/year iron phosphate project and the 500,000-ton/year Ferrous lithium phosphate project through industrial cooperation between iron phosphate and Ferrous lithium phosphate.

　　Yang Junyu, the core technician of Jindike, resigned.

　　Kindike announced that Mr. Yang Junyu, the company’s core technician, recently applied for resignation from relevant positions for personal reasons and completed the resignation procedures. After leaving the company, Mr. Yang Junyu no longer holds any position in the company.

　　Yuntianhua: signed an agreement with Huayou Holdings on the cooperation intention of iron phosphate and Ferrous lithium phosphate projects.

　　Yuntianhua announced on the evening of September 29th that the company and Huayou Holdings signed the Agreement of Intention on Cooperation of Iron Phosphate and Ferrous lithium phosphate Project. The two sides intend to jointly promote the construction and operation of the 500,000-ton/year iron phosphate project and the 500,000-ton/year Ferrous lithium phosphate project. Huayou Holdings intends to transfer 49% equity of Yunnan Yunjuneng New Materials Co., Ltd. held by the company through the open trading market; The company intends to acquire 49% equity of Yunnan Youtian New Energy Technology Co., Ltd. held by Huayou Holdings; After Huayou Holdings receives 49% equity of Juneng New Materials Company, Juneng New Materials Company will be responsible for the construction (or acquisition) and operation of the 500,000 tons/year iron phosphate project.

　　Three Gorges Energy appoints Yang Guifang as Chief Accountant.

　　Three Gorges Energy announced that the board of directors agreed to appoint Mr. Yang Guifang as the company’s chief accountant, with the term of office from the date of deliberation and approval by the board of directors to the expiration of the term of office of the second board of directors.

　　Top group plans to set up a new subsidiary in Mexico and invest in the factory. The total investment is expected to not exceed 200 million US dollars.

　　() Announcement, the company plans to set up a new wholly-owned subsidiary "Top Group Mexico Co., Ltd." in Mexico and invest in the factory. It is estimated that the total investment will not exceed 200 million US dollars. The registered address of the subsidiary is located in Nuevo Leó n, Mexico.

　　It is reported that this company plans to invest and build a factory in Mexico, mainly producing lightweight chassis, interior systems, thermal management systems and robot actuators.

　　Building an industrial ecological chain Yuntianhua plans to jointly promote the construction of iron phosphate and Ferrous lithium phosphate projects with Huayou Holdings.

　　Yuntianhua announced that on September 29th, 2022, the Company ("Party A") and Zhejiang Huayou Holding Group Co., Ltd. ("Huayou Holding" and "Party B") signed the Agreement of Intention on Cooperation of Iron Phosphate and Ferrous lithium phosphate Project in Kunming, Yunnan. The two sides intend to build a more complete and competitive industrial ecological chain through industrial cooperation between iron phosphate and Ferrous lithium phosphate, and promote the construction and operation of the 500,000-ton/year iron phosphate project and the 500,000-ton/year Ferrous lithium phosphate project.

　　It is reported that the cooperation includes: Party B intends to acquire 49% equity of Yunnan Yunjuneng New Materials Co., Ltd. ("Juneng New Materials") held by Party A through the open trading market. Party A intends to acquire 49% equity of Yunnan Youtian New Energy Technology Co., Ltd. ("Yunnan Youtian") held by Party B.. After Party B receives 49% equity of Juneng New Materials Company, Juneng New Materials Company will be responsible for the construction (or acquisition) and operation of the 500,000-ton/year iron phosphate project.

　　Three Gorges Energy plans to jointly invest 10 billion yuan with Yangtze Power to set up a new energy investment company.

　　Three Gorges Energy announced that in order to comprehensively enhance the company’s new energy project resource acquisition strength, expand its new energy business in Inner Mongolia Autonomous Region, and further enhance its resource advantages and scale breakthrough, it is planned that Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment will jointly invest and establish Inner Mongolia Three Gorges Land New Energy Investment Co., Ltd. in Inner Mongolia Autonomous Region to comprehensively carry out the acquisition, development and construction of new energy resources. Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment subscribed RMB 3.4 billion, RMB 3.3 billion, RMB 1.65 billion and RMB 1.65 billion respectively, accounting for 34%, 33%, 16.5% and 16.5% of the registered capital of onshore investment companies respectively.

　　Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group. Changjiang Electric Power, Three Gorges Capital and Three Gorges Investment are affiliated legal persons of the company, and the company, Yangtze Electric Power, Three Gorges Capital and Three Gorges Investment jointly invested and established the company to form related transactions. This time, the company jointly invested with Changjiang Electric Power, Three Gorges Capital and Three Gorges Investment to set up an onshore investment company, which is an important measure to implement the company’s development strategy and has great strategic significance for the company to vigorously develop new energy sources in Inner Mongolia.

　　Three Gorges Energy plans to jointly invest 10 billion yuan with Yangtze Power to set up a new energy investment company.

　　Three Gorges Energy announced that in order to comprehensively enhance the company’s new energy project resource acquisition strength, expand its new energy business in Inner Mongolia Autonomous Region, and further enhance its resource advantages and scale breakthrough, it is planned that Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment will jointly invest and establish Inner Mongolia Three Gorges Land New Energy Investment Co., Ltd. in Inner Mongolia Autonomous Region to comprehensively carry out the acquisition, development and construction of new energy resources. Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment subscribed RMB 3.4 billion, RMB 3.3 billion, RMB 1.65 billion and RMB 1.65 billion respectively, accounting for 34%, 33%, 16.5% and 16.5% of the registered capital of onshore investment companies respectively.

　　Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group. Changjiang Electric Power, Three Gorges Capital and Three Gorges Investment are affiliated legal persons of the company, and the company, Yangtze Electric Power, Three Gorges Capital and Three Gorges Investment jointly invested and established the company to form related transactions. This time, the company jointly invested with Changjiang Electric Power, Three Gorges Capital and Three Gorges Investment to set up an onshore investment company, which is an important measure to implement the company’s development strategy and has great strategic significance for the company to vigorously develop new energy sources in Inner Mongolia.

　　Three Gorges Energy: 3.4 billion yuan is planned to join the Three Gorges Onshore New Energy Investment Company in Inner Mongolia.

　　Three Gorges Energy announced on the evening of September 29th that the company plans to jointly invest with Changjiang Power, Three Gorges Capital and Three Gorges Investment to establish Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd. to comprehensively carry out the acquisition, development and construction of new energy resources. The registered capital of the company to be established is 10 billion yuan, and the amount subscribed by the company is 3.4 billion yuan, accounting for 34% of the capital contribution. Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group.

　　Su Pengfei, Chief Financial Officer of Zhimingda, resigned.

　　Zhimingda announced that the board of directors of the company recently received a written resignation application from Mr. Su Pengfei, the company’s chief financial officer. Mr. Su Pengfei applied to resign as the company’s chief financial officer for personal reasons. After his resignation, Mr. Su Pengfei will no longer hold any position in the company.

　　Three Gorges Energy: 3.4 billion yuan is planned to join the Three Gorges Onshore New Energy Investment Company in Inner Mongolia.

　　Three Gorges Energy announced on the evening of September 29th that the company plans to jointly invest with Changjiang Power, Three Gorges Capital and Three Gorges Investment to establish Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd. to comprehensively carry out the acquisition, development and construction of new energy resources. The registered capital of the company to be established is 10 billion yuan, and the amount subscribed by the company is 3.4 billion yuan, accounting for 34% of the capital contribution. Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group.

　　Lushan New Material: Jiangsu Lushan was selected as a national "Little Giant" enterprise specializing in specialty and novelty.

　　() Announcement: According to the "Announcement on the List of the Fourth Batch of Small Giant Enterprises with Specialization and Novelty and the First Batch of Small Giant Enterprises with Specialization and Novelty in Jiangsu Province" issued by the Jiangsu Provincial Department of Industry and Information Technology, Jiangsu Lushan New Materials Co., Ltd. ("Jiangsu Lushan"), a wholly-owned subsidiary of the company, was selected as a national small giant enterprise with specialization and novelty, with a validity period of 3 years.

　　Shibei High-tech: Participating in the placement of A-share IPO strategic investors of Canrui Technology.

　　() Announcement, the company participated in the strategic investor placement of A-share IPO of Canrui Technology, and the number of shares to be placed was 176,595, and the allocated amount was 20 million yuan.

　　Zhao Jian and Xu Minbo, directors of Jinzheng Co., Ltd., have reduced their holdings by 1.06% for more than half of the time.

　　() Announcement was issued. As of the disclosure date of the announcement, the reduction time set in this reduction plan has been more than half. Director Zhao Jian has reduced the company’s shares by 914,600 shares through centralized bidding transactions, accounting for 0.1% of the company’s total share capital. Director Xu Minbo has reduced the company’s shares by 9,044,100 shares through centralized bidding transactions, accounting for 0.96% of the company’s total share capital. This reduction plan has not yet been implemented.

　　Shibei High-tech participates in the IPO strategic placement of Canrui Technology and plans to receive 176,600 shares.

　　Shibei Gaoxin announced that the company participated in the strategic investor placement of A-share IPO of Canrui Technology with its own funds. The price of the shares issued by Canrui Technology this time was 112.69 yuan/share, and the subscription price of A-shares to be issued under the strategic placement was the same as that of A-shares. The number of shares to be allotted to the company is about 176,600, and the allocated amount is about 20 million yuan. The allocated shares of the company will be locked for 12 months from the date when the shares of Canrui Technology are listed on the Shanghai Stock Exchange in science and technology innovation board.

　　CITIC Investment Holdings, the major shareholder of Heforging Intelligent, reduced its holdings by 1%, and reduced its holdings by more than half.

　　() Announcement: As of September 28, 2022, CITIC Investment Holdings Co., Ltd. ("CITIC Investment Holdings"), a shareholder holding more than 5% of the company’s shares, has reduced its holdings by 4,944,100 shares through centralized bidding, accounting for 1% of the company’s total share capital, and this reduction plan has reduced its holdings by more than half.

　　Hongdu Airlines’ shareholding company Zhongchuang Singapore Airlines will be listed on the main board of the Hong Kong Stock Exchange on October 6.

　　() Announced that Zhongchuang Singapore Airlines Technology Co., Ltd. (hereinafter referred to as "Zhongchuang Singapore Airlines"), the company’s shareholding company, plans to sell 266 million H shares worldwide at a price of HK$ 38.00-51.00 per share, and listed on the main board of the Hong Kong Stock Exchange on October 6, 2022, with the share code of 3931. Before the global sale of Zhongchuang Singapore Airlines was completed, the company held 1,380,600 shares of Zhongchuang Singapore Airlines, accounting for about 0.09% of its total share capital.

　　Weir intends to sell RF-related products and RF test equipment to Xinghao Communication at a price of 184 million yuan.

　　() Announcement, the company intends to sell RF-related products and RF test equipment to the related party Xinghao Communication Technology (Zhejiang) Co., Ltd. (hereinafter referred to as "Xinghao Communication"), with a transaction amount of about 184 million yuan (excluding tax).

　　According to the announcement, in June, 2022, the company divested the RF business that failed to maximize its development space in order to seek better opportunities for industrial development and integration. The company sold RF products and RF test equipment to Xinghao Communication this time as a follow-up arrangement for the above matters.

　　Zhu Xin Rui Kang, a shareholder of ST Mingcheng, released the pledge of 51,611,100 shares.

　　() Announcement was issued. On September 29th, the company received a notice from the shareholder Zhuxin Ruikang about the pledge cancellation of some shares held by the company. Zhuxin Ruikang handled the pledge cancellation procedures for 51,611,100 shares (accounting for 8.83% of the company’s total share capital) of unrestricted shares pledged to Wuhan Yulong Enterprise Management Consulting Co., Ltd. in China Securities Depository and Clearing Co., Ltd.

　　Shanghai Electric Power plans to carry out perpetual trust financing of no more than 4.95 billion yuan with Bairui Trust, a subsidiary of the controlling shareholder.

　　() Announcement: In order to optimize the company’s asset-liability structure and ease the operating pressure of energy supply enterprises, the company plans to carry out perpetual trust financing with Bairui Trust Co., Ltd. ("Bairui Trust"), a holding subsidiary of the controlling shareholder State Power Investment Group Co., Ltd. ("State Power Investment Group"). It is reported that Barry Trust intends to issue trust products to raise funds, and will invest the funds raised from the issuance of trust products in Shanghai Electric Power and its subsidiaries through perpetual trust.

　　Renfu Medicine: Notice of Approval of Remazolam Benzenesulfonate for Injection for Supplementary Application of Drugs

　　() On the evening of September 29th, it was announced that Yichang Renfu, a holding subsidiary, recently received the Notice of Approval for Drug Supplement Application of Remazolam Benzenesulfonate for Injection and the Notice of Approval for Drug Supplement Application of Nabufen Hydrochloride Injection, which were approved and issued by National Medical Products Administration, and agreed to add the indication of "used for sedation in bronchoscopy diagnosis and treatment" to the 50mg specification of Remazolam Benzenesulfonate for injection. Approved the increase of 1ml:10mg specification for Nabufen Hydrochloride Injection.

　　(): Some subsidiaries have invested heavily in scientific research for civil aircraft business and have become supporting suppliers for C919 projects.

　　Avic Electronics announced that on September 29th, 2022, Avic Electronics held an investor communication activity with the theme of "Institutional Investors Entering Avic Electronics" in Shanghai. Among them, regarding the question, "At present, C919 is in the stage of obtaining evidence, and domestic substitution continues to advance. What is the current progress of the company’s civil aircraft support?" , listed companies reply as follows:

　　"The international situation is constantly changing. Domestic substitution is not only a technical issue, but also an issue of international relations. At present, the gap between China’s civil aircraft mainly lies in airworthiness and cost. At present, there are three ways to participate in supporting civil aircraft, the first is to directly support commercial aircraft, the second is to support upstream and downstream through the industrial chain, and the third is to participate in product research and development. At present, the company’s civil aircraft business is still in the early stage of investment, and it is exploring the construction of civil aircraft system. Some subsidiaries have invested heavily in civil aircraft business and have become supporting suppliers for the C919 project. The company will vigorously develop civil aviation-related businesses in the future. With the gradual improvement of the localization rate of C919, there is still a lot of room for incremental development of the company’s civil aviation business. "

　　Renfu Medicine: Remazolam Benzenesulfonate for Injection 50mg specification added indications.

　　Renfu Medicine announced that Yichang Renfu, a holding subsidiary of the company, recently received the Notice of Approval for Supplementary Application of Remimazzolam Benzenesulfonate for Injection, which was approved and issued by National Medical Products Administration. After examination, the application items of this drug met the relevant requirements of drug registration, and it was agreed that the indication of "sedation for bronchoscopy diagnosis and treatment" should be added to the 50mg specification of this drug. The instruction manual shall be implemented as attached, the label shall be updated according to the instruction manual, and other contents shall be implemented as originally approved.

　　The indication of "sedation for bronchoscopy diagnosis and treatment" was added to the 50mg specification of ramizolam besylate for injection. Up to now, Yichang Renfu has invested about RMB 120 million in the R&D project of Remazolam Benzenesulfonate for Injection. In 2021, the market sales of remazolam besylate for injection in Yichang Renfu will be about RMB 60 million. The 50mg specification of ramizolam besylate for injection will add new indications, which will help to expand the application scope of this product and bring positive influence to the company.

　　Renfu Medicine: The specification of 1ml:10mg was added to Nabufen Hydrochloride Injection.

　　Renfu Medicine announced that Yichang Renfu, a holding subsidiary of the company, recently received the Notice of Approval for Supplementary Application of Nabufen Hydrochloride Injection approved and issued by National Medical Products Administration, approved the increase of the specification of the drug by 1ml:10mg, and issued a new drug approval number. The process information table shall be executed as attached. Add corresponding specifications to the quality standards, specifications and labels, and the rest shall be implemented according to the original approved contents.

　　Nabufen hydrochloride injection is widely used to relieve moderate to severe pain and can also be used as anesthesia induction during compound anesthesia. Yichang Renfu’s Nabufen Hydrochloride Injection has been approved with a specification of 2ml:20mg, and this time it was approved to add a specification of 1ml:10mg. Yichang Renfu submitted a supplementary application to National Medical Products Administration in March, 2022, and it was accepted. Up to now, the accumulated R&D investment of this project is about RMB 5 million. In 2021, the sales of Yichang Renfu Nabufen Hydrochloride Injection was about 590 million yuan. The new specifications of Nabufen Hydrochloride Injection will help to expand the application scope of the product and bring positive influence to the company.

　　Baida Group recently recovered the principal of entrusted wealth management of 244 million yuan and gained 1,887,300 yuan.

　　() Announcement: From August 16, 2022 to September 29, 2022, the company redeemed 244 million yuan of bank wealth management products, recovered 244 million yuan of the principal of the above wealth management products, and received corresponding income of 1,887,300 yuan.

　　As of the disclosure date of this announcement, the balance of entrusted wealth management of the company was 856 million yuan, including 295 million yuan of bank wealth management products, 90 million yuan of brokerage wealth management products and 471 million yuan of trust products.

　　Wuzhou Special Paper shareholder Gudao Xufeng reduced its holdings of 3,604,500 shares in the second phase for more than half of the time.

　　() Announcement was issued. On September 29, 2022, the company received the Notice Letter on the Progress of Reduction issued by the shareholder Gudao Xufeng Phase II. Gudao Xufeng Phase II has reduced its holdings by 1,104,500 shares through centralized bidding since June 30, 2022, accounting for 0.28% of the company’s current total share capital; 2.5 million shares were reduced through block trading, accounting for 0.62% of the company’s current total share capital. More than half of the time has passed since the shareholding reduction, and the shareholding reduction plan has not yet been implemented.

　　Kuncai Technology was approved to issue no more than 60 million shares in private.

　　(Announcement) Recently, the company received the Reply on Approving the Non-public Issuance of Shares by Fujian Kuncai Materials Technology Co., Ltd. issued by China Securities Regulatory Commission ("China Securities Regulatory Commission"), and the China Securities Regulatory Commission approved the non-public issuance of no more than 60 million new shares, resulting in changes in the total share capital, and the number of this issuance can be adjusted accordingly. The reply is valid for 12 months from the date of approval of issuance.

　　Jianghang Equipment will increase 4 shares for every 10 shares in half a year, and date of record will be on October 12th.

　　Jianghang Equipment announced that the company will implement the equity distribution and capitalization of capital reserve in the first half of 2022, and transfer 0.4 shares per share from capital reserve to all shareholders, with date of record on October 12th.

　　Daming City repurchased 24.75 million A shares at a cost of 80.2663 million yuan.

　　() Announcement was issued. As of September 29th, 2022, the company has repurchased 24.75 million A shares through centralized bidding, accounting for 1.00% of the company’s total share capital, an increase of 0.85% compared with the last disclosure. The highest price purchased is 3.42 yuan/share, and the lowest price is 3.16 yuan/share, and the total amount paid is 80.2663 million yuan.

　　Yuguang Gold Lead and its subsidiaries received government subsidies of 46,985,500 yuan.

　　() Announced that the company and its subsidiaries recently received a total of RMB 46,985,500 from the government.

　　Sirui New Materials newly identified Ma Mingyue and Zhou Xing as core technicians.

　　Sirui New Materials announced that according to the strategic development plan, the company comprehensively considered the actual situation of the company’s core technology research and development, and after research by the management, Mr. Liu Kai was no longer responsible for specific research and development projects and was no longer recognized as the company’s core technical personnel, and his other positions in the company remained unchanged.

　　In addition, Ms. Ma Mingyue and Mr. Zhou Xing were considered as the core technicians of the company at the fourth meeting of the third board of directors held on September 28, 2022, in combination with their knowledge background and professional experience, as well as their participation in the research and development of the company’s core technologies.

　　Zhao Zhihua, a shareholder of Quanyangquan, and concerted parties have reduced their holdings by 4,481,100 shares.

　　() Announcement was issued. As of the disclosure date of the announcement, Zhao Zhihua, a shareholder holding more than 5% of the shares, and concerted parties reduced their holdings of 4,481,100 shares of the company through centralized bidding. This reduction plan has been implemented.

　　Jiangsu Branch of China Construction Bank, the major shareholder of China Merchants Nanyou, has reduced its holdings of 24.264 million shares by more than half.

　　() Announcement: As of September 28, Jiangsu Branch of China Construction Bank Co., Ltd. ("CCB Jiangsu Branch"), the shareholder of the company, reduced its shareholding by 24.264 million shares through centralized bidding, accounting for 0.5% of the company’s total share capital. More than half of the reduction plans have been made, and its shareholding ratio has dropped to 5.02%.

　　Jiangsu Branch of China Construction Bank, the major shareholder of China Merchants Nanyou, has reduced its holdings of 24.264 million shares by more than half.

　　China Merchants Nanyou announced that as of September 28, Jiangsu Branch of China Construction Bank Co., Ltd. ("CCB Jiangsu Branch"), a shareholder of the company, reduced its shareholding by 24.264 million shares through centralized bidding, accounting for 0.5% of the company’s total share capital. More than half of the reduction plans have been made, and its shareholding ratio has dropped to 5.02%.

　　Traffic Control Technology has received a total of 29.6741 million yuan of government subsidies.

　　Jiaokong Technology announced that the company and its wholly-owned subsidiaries Chengdu Jiaokong, Foshan Jiaokong, etc. and Hangzhou Jiaokong, the holding sun company, received a total of 29.6741 million yuan in government subsidies from December 21, 2021 to September 29, 2022.

　　Tianyao Co., Ltd.: Methylprednisolone Succinate API product obtained CEP certificate.

　　() Announcement. Recently, the company received the European Pharmacopoeia Applicability Certification Certificate ("CEP Certificate") on methylprednisolone succinate API issued by the European Drug Quality Administration ("EDQM").

　　It is reported that methylprednisolone succinate belongs to glucocorticoid drugs and is mainly used for anti-inflammatory treatment, such as rheumatic diseases, collagen diseases, skin diseases, allergic States, eye diseases, gastrointestinal diseases, respiratory diseases and edema States; Immunosuppression therapy (organ transplantation, blood diseases, tumors), treatment of shock, etc.

　　This time, the company’s raw material drug methylprednisolone succinate has obtained CEP certificate, which shows that the raw material drug meets the quality requirements of the European Pharmacopoeia, shows the recognition and affirmation of the quality of the raw material drug in the European standardized market, and indicates that the raw material drug can be sold in the European market and other standardized markets that recognize CEP certificate, which has a positive impact on the company’s further expansion of the international market.

　　Qisheng Technology: It is planned to jointly set up a sleep digital therapy fund with Shanghai Guoke Longhui.

　　() Announcement, the company intends to jointly establish the Sleep Digital Therapy Fund with Shanghai Guoke Longhui, and the company intends to participate in the establishment of the fund as a limited partner, and plans to subscribe for the fund share with no more than 599.5 million yuan. The partnership mainly invests in emerging technology industry companies of sleep digital therapy and other high-quality companies related to ecology.

　　O ‘Neill Center, the shareholder of Haitai Xinguang, reduced its shareholding by 1.13%.

　　Haitai Xinguang announced that on September 29th, 2022, the company received the Notice on Reducing Shares by More than 1% from Shanghai O ‘Nair Venture Capital Center (Limited Partnership), a shareholder of the company, which reduced its shareholding by 982,100 shares, accounting for 1.1291% of the company’s total share capital.

　　Baoshan iron & steel plans to pay a cash dividend of 0.18 yuan per share on October 13th.

　　() Announcement, the company plans to distribute a cash dividend of RMB 0.18 (including tax) per share in the equity distribution in the first half of 2022, and the cash dividend will be distributed on October 13, 2022.

　　Tianyao Co., Ltd.: methylprednisolone succinate API obtained CEP certificate.

　　Tianyao Co., Ltd. announced on the evening of September 29 that it had received the European Pharmacopoeia suitability certificate issued by the European Drug Quality Administration, which indicated that the API could be sold in the European market and other regulated markets that recognized CEP certificate. Methylprednisolone succinate belongs to glucocorticoid drugs and is mainly used for anti-inflammatory treatment, such as rheumatic diseases, collagen diseases and skin diseases.

　　Dongan power received a government subsidy of 21.1699 million yuan.

　　() Announcement was issued. On September 29th, 2022, the company received a total of 21,169,900 yuan (unaudited) from the government.

　　Qisheng Technology plans to spend nearly 600 million yuan to participate in the Sleep Digital Therapy Fund.

　　Qisheng Technology announced that the company plans to jointly establish Qisheng Technology Sleep Digital Therapy Transformation Fund Partnership (Limited Partnership) with Shanghai Guoke Longhui Private Equity Fund Management Co., Ltd. ("Shanghai Guoke Longhui"). The total amount of the fund to be raised is 600 million yuan, and the company plans to subscribe for the fund share with no more than 599.5 million yuan, and the subscription share is 99.92%.

　　It is reported that sleep health is an important part of quality of life and happiness index. According to the White Paper on Exercise and Sleep in 2021 issued by China Sleep Research Association, there are over 300 million people with sleep disorders in China, which is a huge population base and a huge market resource. The company has been promoting the two-way service of scientific and technological hardware products and big health data on the smart bed subdivision track. By participating in the establishment of the sleep digital therapy fund, it will help the company actively find and explore high-quality growth enterprises with advanced technology and innovative technology related to the company’s main business, and take advantage of the company’s project resources to accelerate the company’s more extensive and in-depth layout in the big health and digital fields.

　　Chen Baoguo, director and general manager of Luyin Investment, resigned.

　　() Announcement was issued. On September 29th, 2022, the board of directors of the company received a written resignation report submitted by Mr. Chen Baoguo, the company’s director and general manager. Due to work reasons, Mr. Chen Baoguo applied to resign as a director, general manager and special committee of the board of directors.

　　The 42nd meeting of the 10th Board of Directors of the Company reviewed and approved the Proposal on Appointing the General Manager of the Company, and appointed Mr. Zhao Xiyu as the general manager of the Company, with the term of office from the date of appointment to the expiration of the term of the current Board of Directors.

　　Qisheng Technology granted 5,497,700 stock options at an exercise price of 13.09 yuan/share.

　　Qisheng Technology announced that the grant conditions stipulated in the company’s 2022 stock option incentive plan have been achieved. The company decided to grant 5,497,700 stock options to 246 incentive objects meeting the grant conditions on September 29, 2022, with an exercise price of 13.09 yuan/share.

　　Qisheng Technology: It is planned to invest in the establishment of sleep digital therapy fund.

　　On the evening of September 29th, Yusheng Technology announced that the company intends to jointly establish the Yusheng Technology Sleep Digital Therapy Transformation Fund Partnership (Limited Partnership) (referred to as "Sleep Digital Therapy Fund") with Shanghai Guoke Longhui Private Equity Fund Management Co., Ltd.. The fund plans to raise a total of 600 million yuan, of which the company plans to participate in the establishment of the fund as a limited partner, and plans to subscribe for the fund share of no more than 599.5 million yuan, with a subscription share of 99.92%. The fund mainly invests in emerging technology industry companies of sleep digital therapy and other high-quality companies related to ecology.

　　Taiheshui: change of office address of the company

　　() After-hours announcement on September 29th said that the company had recently moved from "No.256 Xiangyin Road, Yangpu District, Shanghai" to "Lanyun Cultural Center, Lane 899, Panlong Road, Qingpu District, Shanghai", and its postal code was changed from "200433" to "201702". Except for the above changes, other basic information such as the registered address, e-mail address and contact telephone number of the company remain unchanged.

　　Shandong Glass Fiber intends to sell 100 kilograms of precious metal rhodium powder.

　　() Announcement: In recent years, through continuous rhodium bushing reduction test and realistic production site, the rhodium bushing reduction technology has gradually matured, and the amount of rhodium powder has gradually decreased. In order to revitalize the existing assets, optimize the asset structure and further improve the quality of asset operation, the company plans to sell 100 kilograms of precious metal rhodium powder for daily production and operation in the second half of 2022.

　　Shandong glass fiber: 100 kg rhodium powder will be sold according to the market situation of precious metals.

　　Shandong Glass Fiber announced on the evening of September 29th that in recent years, the amount of rhodium powder has gradually decreased through continuous rhodium leakage reduction test and realistic production site. According to the company’s development strategy and precious metal market situation, 100 kg rhodium powder will be sold at the right time.

　　BC008-1A injection, a subsidiary of Buchang Pharmaceutical Co., Ltd., will officially carry out phase I clinical trial.

　　() Announcement: Recently, Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd., a holding subsidiary of the company, obtained the Approval Report of Ethics Committee of Cancer Hospital of National Cancer Center/Peking Union Medical College of China Academy of Medical Sciences, and officially launched Phase I clinical trial.

　　BC008-1A injection (recombinant anti-PD-1/TIGIT humanized bispecific antibody injection) is a kind of bispecific drug that specifically targets PD-1 and TIGIT. It can directly block the signaling pathways of PD-1 and TIGIT, relieve the inhibition of T lymphocytes, thus facilitating the activation of T cells, enhancing the immune monitoring, identifying and killing tumor cells, and blocking the potential synergy between PD-1 and TIGIT. The main indication of BC008-1A injection is advanced solid tumor. At present, there are no similar dual-target drugs approved for marketing at home and abroad. In September, 2022, it obtained the Notice of Approval of Drug Clinical Trials. As of August 31, 2022, the R&D expenditure invested in this project was about RMB 34,498,100.

　　ST Rongtai: Transfer subsidiaries to dispose assets and strengthen compliance management.

　　() On the evening of September 28th, a progress announcement on the transfer of 100% equity of a wholly-owned subsidiary was issued. The company has received a deposit of RMB 1 million from Guangzhou Jiaxin Clothing Co., Ltd. and completed the industrial and commercial change registration procedures. At this point, the company no longer holds the equity of Hefuxin materials, and Hefuxin materials are no longer included in the scope of the company’s consolidated statements. The previous announcement showed that the pricing of the subject matter of this transaction was initially determined to be 69 million yuan.

　　Combing the recent actions of ST Rongtai, it is found that the company is constantly strengthening compliance management and its development is gradually on the right track. Prior to this, the Company had held the fourth and fifth extraordinary shareholders’ meetings in succession, and passed the proposals on revising the Management System of External Guarantee, formulating the Management Measures for Preventing the Controlling Shareholders or Actual Controllers and Their Related Parties from Taking up Funds, formulating the Code of Conduct for Controlling Shareholders and Actual Controllers and transferring 100% equity of wholly-owned subsidiaries.

　　Previous announcements showed that the controlling shareholder of the company and its related parties returned the occupied company funds totaling 194 million yuan from January to May 2022 and June 1, 2022; From June 2, 2022 to June 23, 2022, the company’s occupied capital of RMB 4,554,500 was returned in cash; On June 27th, 2022, RMB 130 million was returned in cash. As of June 27, 2022, the controlling shareholder and its related parties have returned 328 million yuan of funds occupied by listed companies, and all the non-operating funds occupied by the controlling shareholder and its related parties have been returned. At this point, the situation that the company’s stock touches the first item of Article 9.8.1 of the Listing Rules of Shanghai Stock Exchange (revised in January 2022) has been eliminated.

　　In addition, the company actively communicated with the court and creditors to jointly solve the debt problem and lift the frozen state of bank accounts. Since May 20th this year, ST Rongtai has reached a debt settlement with financial machine buyers and suppliers such as Bank of Hebei, Guangfa Financial Leasing, Jinwo Leasing and Guangzhou Tianhe Agricultural Materials, and paid the corresponding settlement fees. At the same time, the company plans to dispose of idle more than 1,000 mu of land and related assets.

　　ST Rongtai introduced that in combination with the strategic deployment of the country’s "East Counting and West Counting", the company plans to tilt its capital, manpower and other resources to the Internet service sector in the future. Zhangbei Rongtai Yungu Data Center is located in the Beijing-Tianjin-Hebei hub, an important node of "East Counting and West Computing". In the future, the company plans to lay out a nationwide integrated big data center system, build an operation data center at key computing hub nodes, accelerate the construction of Zhangbei Rongtai Yungu Data Center, and fully guarantee the service of quality customers.

　　Linglong Tire: The actual controller plans to increase its shareholding by 15 million yuan to 20 million yuan.

　　Linglong Tire announced that Wang Xicheng, the actual controller of the company, intends to increase its shareholding within 6 months from the date of this announcement, and the amount of increase is not less than 15 million yuan and not more than 20 million yuan.

　　Three Gorges Energy: 3.4 billion yuan is planned to participate in Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd.

　　Three Gorges Energy announced that the company plans to jointly invest with Yangtze Power, Three Gorges Capital and Three Gorges Investment to establish Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd. to comprehensively carry out the acquisition, development and construction of new energy resources, with a registered capital of 10 billion yuan. Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment respectively subscribed 3.4 billion yuan, 3.3 billion yuan, 1.65 billion yuan and 1.65 billion yuan in cash, accounting for 34% of the registered capital of onshore investment companies respectively. Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group.

　　Three Gorges Energy: 3.4 billion yuan is planned to participate in Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd.

　　Three Gorges Energy announced that the company plans to jointly invest with Yangtze Power, Three Gorges Capital and Three Gorges Investment to establish Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd. to comprehensively carry out the acquisition, development and construction of new energy resources, with a registered capital of 10 billion yuan. Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment respectively subscribed 3.4 billion yuan, 3.3 billion yuan, 1.65 billion yuan and 1.65 billion yuan in cash, accounting for 34% of the registered capital of onshore investment companies respectively. Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group.

　　The total reduction ratio of the three shareholders of Oled reached 2.44%, and the reduction time was more than half.

　　Aolaide announced that on September 29th, 2022, the company received the shareholder Ningbo Luhe Ruineng Investment Partnership (Limited Partnership), Ningbo Luhe Chensheng Venture Capital Partnership (Limited Partnership), Ningbo Yanyuan Yaoshang Industrial Finance Equity Investment Partnership (Limited Partnership) (hereinafter referred to as Ningbo Yanyuan). Ningbo Yanyuan, Lvhe Ruineng and Lvhe Chensheng reduced their holdings of 2,501,100 shares through centralized bidding and block trading, accounting for 2.44% of the company’s total share capital.

　　Hongyi Jiahua, the controlling shareholder of Chengdu Luqiao, completed the reduction of its holdings and reduced its holdings by 1.5%.

　　() Announcement, Hongyi (), the controlling shareholder of the company, has completed the implementation of the reduction plan, and it has reduced the company’s shares by 11.381 million shares, accounting for 1.503% of the total share capital.

　　() The total investment of the proposed 60MW wind power project in Yuershan and the 100MW wind power project in Jingtan Phase II is 1.163 billion yuan.

　　TBEA announced that in order to seize market opportunities and speed up the development of wind resources, the company’s holding companies, Fengning Manchu Autonomous County Xinlong Wind Power Co., Ltd. ("Fengning Company") and Tianmen Tiansheng Wind Power Co., Ltd. ("Tiansheng Company"), will invest in the construction of Fengning Xinlong Yuershan 60MW wind farm project ("Yuershan 60MW wind farm project") and Jingtan Township Wind Power Phase II 100MW project ("Jingtan Township, Tianmen City, Hubei Province)

　　According to the feasibility study report, the construction contents of the 60MW wind power project in Yuershan mainly include 60MW wind turbines and supporting facilities, 35kV switching stations, on-site power transmission and transformation lines and maintenance roads. The construction contents of the 100MW project of Jingtan Wind Power Phase II mainly include 100MW wind turbines and supporting facilities, on-site transmission lines and maintenance roads. The construction period of the above projects is 6 months.

　　Shuangliang Energy Saving: It is planned to purchase 65.7 billion yuan of polysilicon materials.

　　() Announcement, it is agreed that from 2022 to 2026, it is estimated to purchase 66,800 tons of polysilicon from Shanghai east hope Energy Holdings Co., Ltd., and the estimated purchase amount is about 20.24 billion yuan. It is agreed that from 2023 to 2030, it is estimated to purchase 150,000 tons of polysilicon from Xinte Energy Co., Ltd., and the estimated purchase amount is about 45.45 billion yuan.

　　Haiqi Group: Passenger transport on each line has resumed operation.

　　() Announcement: Up to now, except for the main business premises (passenger station) of a subordinate unit of Wanning Branch and the passenger transportation of the class line, the business premises (passenger stations) of other cities and counties have resumed production and operation, and the passenger transportation of each class line has resumed operation in an orderly manner.

　　The transfer price of industrial park plots and above-ground buildings to be publicly disposed of by Xiamen Industrial Co., Ltd. was initially determined to be 773 million yuan.

　　() Announcement: In order to rationally allocate the resources of the two production bases in Xiamen and Jiaozuo, Henan, the company plans to publicly dispose of the "998 Logistics Park" plot of the B2 plot of the industrial park, the C2 plot and the above-ground buildings (including ancillary facilities). As of June 30, 2022, the appraised value of the land use right and the above-ground buildings (including ancillary facilities) involved in the disposal of assets is RMB 773 million (including value-added tax), and the transfer price is initially determined to be RMB 773 million (including value-added tax).

　　Ningbo Port: The container throughput is expected to be 3.22 million TEUs in September, up 2.0% year-on-year.

　　() Announcement: It is estimated that the container throughput will be 3.22 million TEUs in September, up 2.0% year-on-year; It is estimated that the cargo throughput will be 80.72 million tons, a year-on-year increase of 1.0%. In the first three quarters of 2022, the company expects to complete a total container throughput of 31.78 million TEUs, a year-on-year increase of 9.4%; It is estimated that the accumulated cargo throughput will be 796.36 million tons, up 4.6% year-on-year.

　　Weiming Environmental Protection: It is planned to invest 10.8 billion yuan with Gemei to build a low-carbon industrial park for new energy battery materials in Wenzhou.

　　() Announcement, the company, Yongqing Technology, () and Wenzhou High-tech Industrial Development Zone Management Committee and Wenzhou Dongtou District Government signed a strategic cooperation framework agreement in Wenzhou to build a world-class green circular economy industrial park and a low-carbon industrial park for new energy battery materials. Wenzhou Green Circular Economy Industrial Park Project, with a total investment of 2.2 billion yuan, plans to build a green circular economy industrial park with an annual capacity of 100,000 tons of power batteries and battery waste recycling and 100,000 scrapped cars recycling. Wenzhou new energy battery material low-carbon industrial park, planning to invest in a new base with an annual output of 600,000 tons of nickel cobalt manganese sulfuric acid crystal material and 50,000 tons of ultra-high nickel ternary precursor material; Invest in a new high-purity lithium carbonate material base with an annual output of 45,000 tons; With attracting enterprises as the main body, we will invest in three new bases with an annual output of 100,000 tons of electrolyte materials, as well as projects such as attracting graphene anode materials and separator materials industrial chain, with a total planned investment of about 10.8 billion yuan.

　　73.588 million restricted shares of Chun Xue Food will be listed and circulated on October 13th.

　　() Announced that the restricted shares listed and circulated this time are the company’s initial public offering of restricted shares, totaling 73.588 million shares, and the lock-up period is 12 months from the date of listing of the company’s shares. Now the lock-up period is about to expire and will be listed and circulated on October 13.

　　() The interim dividend of 2022 A shares will be paid on October 13th, with a dividend of 0.60844 yuan per share.

　　China CNOOC announced that the company will pay the interim dividend of 2022 A shares on October 13th, 2022, with RMB 0.60844 (including tax) per share. The date of record of this equity distribution is October 12, 2022, and the ex-dividend date is October 13, 2022.

　　Zhenjiang Co., Ltd. plans to increase the capital of its subsidiary Tianjin Zhenjiang by 57 million yuan.

　　() Announce that according to the company’s strategic development plan for the photovoltaic market and the business development needs of Tianjin Zhenjiang, in order to further enhance the financial strength of Tianjin Zhenjiang and promote the smooth implementation of the company’s overall strategic development plan, the company plans to increase the capital of Tianjin Zhenjiang, a wholly-owned subsidiary, by 57 million yuan with its own funds. After the completion of this capital increase, the registered capital of Tianjin Zhenjiang increased from 3 million to 60 million, and the company still holds 100% of its equity.

　　In the first three quarters, Ningbo Port is expected to complete a total container throughput of 31.78 million TEUs, up 9.4% year-on-year.

　　Ningbo Port announced that in September 2022, the company expects to complete the container throughput of 3.22 million TEUs, up 2.0% year-on-year; It is estimated that the cargo throughput will be 80.72 million tons, a year-on-year increase of 1.0%. In the first three quarters of 2022, the company expects to complete a total container throughput of 31.78 million TEUs, a year-on-year increase of 9.4%; It is estimated that the accumulated cargo throughput will be 796.36 million tons, up 4.6% year-on-year.

　　Suzhou Kirin, the shareholder of Aike Technology, reduced its shareholding by 1.34% for more than half of the time.

　　Aike Technology announced that on September 29, 2022, the company received the Notice on the Progress of Share Reduction of Hangzhou Aike Technology Co., Ltd. issued by Suzhou Qilin, a shareholder. As of September 29, 2022, Suzhou Qilin had reduced its shares by 791,600 shares through block trading and centralized bidding, accounting for 1.34% of the company’s total share capital. As of September 29, 2022, the time of this reduction plan has been more than half, and the reduction plan has not yet been implemented.

　　Kunshi Tianli, the shareholder of Zhiyang Innovation, and the concerted parties have not reduced their holdings for more than half of the time.

　　Zhiyang Innovation announced that from the announcement date of this reduction plan to September 28, shareholders Kunshi Tianli, Kunshi Growth, Kunshi Zhichuang and Kunshi Chuangfu did not reduce their shares in the company. The time of this reduction plan has been more than half, and this reduction plan has not yet been implemented.

　　Wanhua Chemical: Increase MDI price in China in October.

　　() Announcement: Since October 2022, the listing price of polymeric MDI in China of Wanhua Chemical Group Co., Ltd. is 19,800 yuan/ton (2,300 yuan/ton higher than that in September); The listing price of pure MDI is 23,000 yuan/ton (2,000 yuan/ton higher than that in September).

　　Wanhua Chemical raised MDI price in China in October.

　　Wanhua Chemical announced that since October 2022, the listing price of polymeric MDI in China area of the company was 19,800 yuan/ton (up 2,300 yuan/ton from September); The listing price of pure MDI is 23,000 yuan/ton (2,000 yuan/ton higher than that in September).

　　Ningbo Energy: A wholly-owned subsidiary plans to invest abroad to set up a project company to carry out comprehensive smart energy projects.

　　() Announcement, the wholly-owned subsidiary plans to invest abroad to set up a project company to carry out comprehensive smart energy projects with a total investment of 75,921,400 yuan.

　　Jiangsu Huachen’s semi-annual equity distribution plans to distribute 0.2 yuan’s ex-dividend on October 13th.

　　() Announce that this profit distribution is based on the total share capital of the company before the implementation of the plan, and a cash dividend of 0.20 yuan (including tax) will be distributed per share.

　　The date of this equity distribution in date of record is October 12, 2022, and the ex-dividend date is October 13, 2022.

　　Wanhua Chemical: Raise the listing price of polymeric MDI in China in October.

　　Wanhua Chemical announced on the evening of September 29 that since October 2022, the listing price of polymeric MDI in China area of the company has been 19,800 yuan/ton, up 2,300 yuan/ton from September; The listing price of pure MDI is 23,000 yuan/ton, which is 2,000 yuan/ton higher than that in September.

　　Yuntianhua and Huayou Holdings reached a cooperation agreement of 500,000 tons/year of iron phosphate and Ferrous lithium phosphate.

　　On the evening of September 29th, according to the announcement of Yuntianhua, the company and Huayou Holdings signed the Cooperation Agreement on Iron Phosphate and Ferrous lithium phosphate Project, and the two parties intend to promote the construction and operation of the 500,000-ton/year iron phosphate project and the 500,000-ton/year Ferrous lithium phosphate project through industrial cooperation between iron phosphate and Ferrous lithium phosphate.

　　Since the outbreak, countries have attached importance to food security, the global agricultural product prices have soared, and the demand for phosphate fertilizer is strong, so the phosphorus chemical industry as a whole has ushered in a boom cycle. At the same time, with the rapid development of new energy vehicles, the output of phosphorus-based new energy-related materials such as iron phosphate and Ferrous lithium phosphate has increased, and the downstream demand for phosphate ore has ushered in a new growth point.

　　Yuntianhua is rich in phosphate rock resources and coal resources, with an existing raw ore production capacity of 14.5 million tons. It is one of the largest phosphate mining and dressing enterprises in China.

　　In May 2013, Yuntianhua Group injected excellent assets such as phosphate rock, phosphate fertilizer, phosphorus chemical industry, trade logistics and public works into Yuntianhua, realizing the overall listing of the main business of the group company, and also forming the main revenue framework of Yuntianhua today.

　　At present, Yuntianhua’s main business includes fertilizer, fine chemicals and business services. Benefiting from the high prosperity of the fertilizer industry and some fine chemicals, in the first half of 2022, Yuntianhua achieved revenue of 36.623 billion yuan, an increase of 18.4% year-on-year; The net profit of returning to the mother was 3.466 billion yuan, an increase of 120.48% year-on-year, and the performance reached a record high.

　　In recent years, Yuntianhua has closely followed the opportunities of new energy development and actively expanded its new energy industry business by combining its own advantages in resources, technology and industrial chain.

　　On October 30, 2021, Yuntianhua announced that it planned to invest 7.286 billion yuan to build 500,000 tons/year iron phosphate battery new material precursors and supporting projects.

　　Among them, it is planned to invest in a new 100,000-ton/year iron phosphate project and supporting facilities, and it is expected to start full production in September 2022; It is planned to invest in a new 2× 200,000 ton iron phosphate project and its supporting facilities, which is expected to be completed in December 2023. The implementation of this project will further promote the diversified and in-depth development and utilization of Yuntianhua phosphorus resources.

　　The construction of the 100,000-ton/year iron phosphate project in Yuntianhua Phase I is progressing as planned. At present, it has entered the commissioning stage. The second phase of 2× 200,000 tons/year iron phosphate project has completed the filing and grading procedures. According to the report of Yuntianhua Project, after all the projects are completed and put into production, it is estimated that the annual revenue will be 8.537 billion yuan and the net profit will be 938 million yuan.

　　This time, Yuntianhua and Huayou Holdings reached the Agreement on Intention of Cooperation on Iron Phosphate and Ferrous lithium phosphate Projects. The cooperation includes:

　　(1) Huayou Holdings intends to acquire 49% equity of Yunnan Yunjuneng New Materials Co., Ltd. (hereinafter referred to as "Juneng New Materials") held by Yuntianhua through the open trading market; (2) Yuntianhua intends to acquire 49% equity of Yunnan Youtian New Energy Technology Co., Ltd. (hereinafter referred to as "Yunnan Youtian") held by Huayou Holdings; (3) After the transferee is completed, Juneng New Materials will be responsible for the construction (or acquisition) and operation of Yuntianhua 500,000 tons/year iron phosphate project.

　　In addition, Yunnan Youtian is responsible for Yuntianhua 500,000 tons/year Ferrous lithium phosphate project: the first phase is 100,000 tons/year (planned to be completed in 2023); The second phase is 200,000 tons/year (planned to be completed in 2024); The third phase is 200,000 tons/year (planned to be completed in 2025). At present, Yunnan Youtian has completed the filing and evaluation of the Ferrous lithium phosphate project, and is carrying out the preliminary administrative examination and approval of the project.

　　Zhai Xuli, chief analyst of the chemical industry of Shenzhen-Hong Kong Securities, believes. "Yuntianhua relies on its own advantages in phosphate resources to actively expand its new energy industry business. With the continuous increase in the output of new energy vehicles and the installed capacity of Ferrous lithium phosphate, the iron phosphate project is expected to inject new growth momentum into Yuntianhua."

　　(): The restricted shares held by the controlling shareholder, accounting for 31% of the total share capital, were lifted on October 13th, and there is no reduction plan.

　　Rainbow shares announced that the listing type of restricted shares of the company is non-public offering of restricted shares, with the number of 1.113 billion shares, accounting for 31.01% of the company’s total share capital, involving one shareholder, namely Xianyang Financial Holding Group Co., Ltd., which will be listed and circulated on October 13, 2022. After the restricted shares are listed and circulated, the controlling shareholder has no relevant reduction plan for the time being.

　　Ruichuang Micro-nano’s application for issuing convertible bonds was reviewed and approved by Shanghai Stock Exchange.

　　Ruichuang Micro-nano announced that the science and technology innovation board Listing Committee of Shanghai Stock Exchange held the 78th Review Meeting of the Listing Committee in 2022 on September 29th, and reviewed the company’s application for issuing convertible corporate bonds to unspecified objects. According to the results of the meeting, the company’s application for issuing convertible corporate bonds to unspecified objects meets the requirements of issuance, listing and information disclosure.

　　Qisheng Technology plans to invest in the establishment of the Sleep Digital Therapy Fund, which plans to raise 600 million yuan.

　　On September 29th, Yusheng Technology announced that the company plans to jointly set up a sleep digital therapy fund with Shanghai Guoke Longhui Private Equity Fund Management Co., Ltd., and the fund plans to raise a total of 600 million yuan. Yusheng Technology plans to participate in the establishment of the fund as a limited partner, and plans to subscribe for the fund share with no more than RMB 599.5 million.

　　According to reports, the parties to the Sleep Digital Therapy Fund intend to sign the Partnership Agreement of Yusheng Technology Sleep Digital Therapy Transformation Fund (Limited Partnership). The agreement stipulates that the scale of the Sleep Digital Therapy Fund is expected to be 600 million yuan, which will be established in the form of a limited partnership. Among them, Shanghai Guoke Longhui, the general partner, subscribed for 500,000 yuan, accounting for 0.08% of the subscribed capital; Qisheng Technology, a limited partner, has subscribed capital contribution of RMB 599.5 million, accounting for 99.92%. The fund mainly invests in emerging technology industry companies of sleep digital therapy and other high-quality companies related to ecology.

　　The announcement shows that under the premise of ensuring the funds needed for daily operations, Qisheng Technology will use its own funds to invest in funds, which will help the company integrate and utilize the superior resources of all parties, explore investment opportunities, and enhance the company’s capital operation ability through special investment and market-oriented management. There are also risk factors in this investment, which may face the risk of uncertainty in investment income, failure to realize expected income after investment or even loss of investment principal.

　　*ST Fangke: The court allowed the company to continue its business during the reorganization period.

　　() Announced that the company manager received the Reply from Beijing No.1 Intermediate People’s Court on September 29th ((2022) No.249, Beijing No.1 Intermediate People’s Court), and Beijing No.1 Intermediate People’s Court allowed the company to continue its business during the reorganization.

　　If the company is ruled by the court to accept the reorganization, there may be the risk of being declared bankrupt because of the failure of the reorganization. If the company is declared bankrupt, it will be liquidated. According to Article 9.4.13 of the Listing Rules of Shanghai Stock Exchange (revised in January 2022), the company’s shares will face the risk of being terminated from listing.

　　Jianghuai Automobile has received a total of 62,878,500 yuan of government subsidies related to income.

　　() Announcement was issued. As of September 29th, the company and its holding subsidiaries have received a total of 62,878,500 yuan of government subsidies related to income (excluding the government subsidies disclosed by the company in the previous period). The above-mentioned subsidy funds will be included in the current profit and loss in 2022, which will have a positive impact on the company’s profit in 2022.

　　Huarong shares elected Hu Zhirong as the chairman.

　　() Announced, the board of directors of the company reviewed and passed the Proposal on Electing the Chairman of the Company, and Mr. Hu Zhirong was elected as the chairman of the fifth board of directors of the company after being elected by the directors present.

　　Yue Anxin materials shareholders Ruihe Investment and concerted action plan to reduce their holdings by no more than 4.268 million shares.

　　Yue Anxin Materials announced that due to the capital needs of shareholders, the shareholders of the company, Ruihe Investment and its concerted actions, Ruizhi Investment and Ruilan Investment, intend to reduce their holdings of the company’s shares through centralized bidding and block trading, with a total reduction of no more than 2.56 million shares, accounting for no more than 2.9962% of the company’s total share capital. In addition, due to his own capital needs, Yu Yuanbao, the company’s shareholder and director, intends to reduce his holdings of the company’s shares through block trading, with a total reduction of no more than 1.708 million shares, accounting for no more than 1.9990% of the company’s total share capital.

　　Long-term Lithium Branch: "Lithium Branch Convertible Bonds" will be purchased on October 11th.

　　Long-term Lithium announced that the company will issue 3.25 billion yuan of convertible corporate bonds ("convertible bonds"). The convertible bonds issued this time are referred to as "Lithium Convertible Bonds" with the bond code of "118022" and the initial conversion price of 15.76 yuan/share. In addition, the priority placement date of the original shareholders of this convertible bond issue is the same as the online subscription date on October 11th, 2022 (T day), and the online subscription time is 9:30-11:30 and 13:00-15:00 on T day.

　　Yonghe shares: "Yonghe convertible bonds" will be purchased on October 11th.

　　() Announcement, the company will issue 800 million yuan of convertible corporate bonds ("convertible bonds"). The convertible bonds issued this time are referred to as "Yonghe Convertible Bonds" with the bond code of "111007" and the initial conversion price is 33.64 yuan/share. In addition, the original shareholders’ priority placement date and online subscription date of this issue are both October 11th, 2022 (T day), and the online subscription time is 9:30-11:30 and 13:00-15:00 on T day.

　　Fuchuang Precision will be listed in science and technology innovation board on October 10th.

　　Fuchuang Precision announced that the company’s shares will be listed in science and technology innovation board on October 10th, 2022.

　　Pang Shihong, chief financial officer of Yahuilong, has not reduced his holdings for more than half of the implementation period.

　　Yahuilong announced that as of September 29, 2022, Pang Shihong, the company’s chief financial officer and secretary of the board of directors, had been planning to reduce his holdings by centralized bidding, and he had not yet implemented the reduction.

　　Zhenjiang shares: the company’s Dong Jiangao plans to reduce his shares by centralized bidding.

　　Zhenjiang Co., Ltd. announced on the evening of September 29th that Liu Haotang, director and general manager of the company, Zhang Xiaolin, chief financial officer, Yuan Jianjun, secretary of the board of directors, Zhu Xiaoqiu, deputy general manager, and Xu Jianhua, deputy general manager, planned to reduce their holdings by no more than 12,500 shares, 5,000 shares, 7,500 shares, 7,500 shares and 7,500 shares respectively. All the above shares were obtained by the company through the implementation of the second restricted stock incentive plan.

　　Zhuorun Biotech, a subsidiary of Yahuilong Holdings, plans to introduce an employee follow-up platform.

　　Yahuilong announced that Shenzhen Zhuorun Biotechnology Co., Ltd. ("Zhuorun Bio-technology" or "Target Company"), a holding subsidiary of the company, plans to increase capital and introduce an employee follow-up platform. Meanwhile, minority shareholders Su Normal and Yao Yiyu plan to transfer the total equity of Zhuorun Bio-technology held by them to 13.2118%. It is reported that Zhuorun Biotech is mainly engaged in the research and development, production and sales of in vitro diagnostic products.

　　It is reported that Hainan Kai Tak Kang Hua Investment Partnership (Limited Partnership) (tentative name, "Kai Tak Kang Hua") and Hainan Yide Kang Hua Investment Partnership (Limited Partnership) (tentative name, "Yide Kang Hua"), which are currently under preparation, participated in this transaction as two employee investment platforms. Among them, Kai Tak Kang Hua intends to transfer the registered capital of Zhuorun Bio-tech, which is normally held by Su Shi, by RMB 4,420,575. Yide Kang Hua intends to acquire the registered capital of Zhuorun Bio-tech of RMB 337,343,000 normally held by Su and RMB 120,000 registered capital of Zhuorun Bio-tech held by Yao Yiyu at RMB 3 million. Yide Kang Hua plans to subscribe for the newly-increased registered capital of Zhuorun Bio-products of RMB 1,194,006 for RMB 29,850,150.

　　After the completion of this transaction, Kai Tak Kang Hua and Yide Kang Hua held 2.9500% and 27.5500% of the shares of Zhuorun Bio-tech respectively, and the registered capital of Zhuorun Bio-tech increased from 4.8 million yuan to 5.994006 million yuan. The proportion of the shares of Zhuorun Bio-tech held by the company through its wholly-owned subsidiary Hong Kong Diag Challen Biotechnology Limited decreased from 62.5% to 50.05%, and Zhuorun Bio-tech remained a holding subsidiary of the company.

　　Rongbai Technology’s application for issuing shares to specific targets was approved by China Securities Regulatory Commission.

　　Rongbai Technology announced that the company recently received the "Reply on Agreeing to the Registration of Ningbo Rongbai New Energy Technology Co., Ltd. to Issue Stocks to Specific Objects" issued by China Securities Regulatory Commission (hereinafter referred to as the "Reply Document") (No.2246 [2022] of the CSRC). The details are as follows:

　　1. Agree to your company’s application for registration of issuing shares to specific targets. 2. This issuance of your company shall be implemented in strict accordance with the application documents and issuance plan submitted to the Shanghai Stock Exchange. Three, this reply is valid for 12 months from the date of consent to registration. Four, from the date of registration to the end of this issue, if your company has any major events, it shall promptly report to the Shanghai Stock Exchange and handle them according to relevant regulations.

　　648 million restricted shares of Zhuhai Guanyu were listed and circulated on October 17th.

　　Zhuhai Guanyu announced that the restricted shares were released from circulation on October 17, 2022. The total number of restricted shares listed and circulated this time was 648 million shares, accounting for 57.7332% of the company’s total share capital.

　　Tasly: the application for clinical trial of Jiuwei Huaban Pill in the treatment of plaque psoriasis was approved.

　　() Announcement. Recently, the company received the approval of National Medical Products Administration (hereinafter referred to as "National Medical Products Administration") to issue the Notice of Approval for Clinical Trials of Drugs for the Treatment of Plaque Psoriasis with Jiuwei Huaban Pill.

　　It is reported that Jiuwei Huaban Pill has the effects of clearing away heat and toxic materials, promoting blood circulation and removing blood stasis, cooling blood and removing spots, and is intended to be used for treating plaque psoriasis. The pre-clinical pharmacological and toxicological studies have shown that Jiuwei Huaban Pill has a good effect on improving the symptoms of psoriasis-like lesions and abnormal epidermal proliferation, and its safety is good.

　　Tasly: Jiuwei Huaban Pill got the approval notice of drug clinical trial.

　　Tasly announced on the evening of September 29th that the company received the "Notice of Approval for Clinical Trials of Drugs" issued by National Medical Products Administration for the treatment of plaque psoriasis with Jiuwei Huaban Pill.

　　Jianghang Equipment will transfer 4 shares for every 10 shares in the first half of 2022, and date of record will be October 12.

　　() Financial News Jianghang Equipment announced that the content of the company’s half-year equity distribution implementation plan in 2022 is as follows: based on the total share capital of 403,744,500 shares, 4.00 shares will be transferred to all shareholders for every 10 shares with capital reserve, and no dividends will be paid.

　　The distribution of rights and interests in date of record is on October 12th, and the ex-dividend date is on October 13th.

　　According to the semi-annual performance report released by Jianghang Equipment in 2022, the company’s operating income was 586 million yuan, a year-on-year increase of 21.6%; The net profit attributable to shareholders of listed companies was 147 million yuan, a year-on-year increase of 15%; The basic earnings per share was 0.37 yuan, compared with 0.32 yuan in the same period last year.

　　Hefei Jianghang Aircraft Equipment Co., Ltd. is mainly engaged in aviation equipment and special refrigeration, involving R&D, production, sales and repair of aviation products such as aviation oxygen system, airborne fuel tank inert protection system and aircraft auxiliary fuel tank, as well as R&D, production and sales of special refrigeration equipment for military and civilian use. Its products include aviation oxygen system, airborne fuel tank inerting protection system, aircraft auxiliary fuel tank, military special refrigeration equipment, civil special refrigeration equipment, sensitive components, oxygen ground support equipment and maintenance services. The company is the only professional R&D and manufacturing base of aviation oxygen system and inert protection system of airborne fuel tank in China, and also the largest aircraft auxiliary fuel tank and the leading manufacturer of special refrigeration equipment in China. The company’s honors include: the J-X aircraft project won the special prize of the National Science and Technology Progress Award, the research and experimental research of airborne molecular sieve oxygen supply equipment won the second prize of the National Science and Technology Progress Award, the construction project of air force XX mission aviation life-saving system won the second prize of the National Science and Technology Progress Award, and the comprehensive research of clinical brain stereotactic technology won the third prize of the National Science and Technology Progress Award. The company applied for 121 patents and 38 patents were authorized, including 6 invention patents, and 528 patents were authorized.

　　(Source: Straight Flush iFinD)

　　Jiangsu Huachen sent 2 yuan date of record for every 10 shares in the first half of 2022 as October 12th.

　　Straight Flush Financial News Jiangsu Huachen announced that the company’s half-year equity distribution implementation plan for 2022 is as follows: based on the total share capital of 160 million shares, a cash dividend of RMB 2.00 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 32 million will be distributed, accounting for 81.61% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is on October 12th, and the ex-dividend date is on October 13th.

　　According to the 2022 semi-annual performance report released by Jiangsu Huachen, the company’s operating income was 398 million yuan, a year-on-year increase of 2.84%; The net profit attributable to shareholders of listed companies was 39.2125 million yuan, an increase of 8.7% year-on-year; The basic earnings per share was 0.31 yuan, compared with 0.30 yuan in the same period last year.

　　Jiangsu Huachen Transformer Co., Ltd. specializes in R&D, production and sales of transmission and distribution and control equipment. Its main products include dry-type transformers, oil-immersed transformers, box-type substations and complete sets of electrical equipment. As an important part of power system, transmission and distribution and control equipment are widely used in power grid, new energy (wind, light and storage), rail transit, electric vehicle charging pile, industrial manufacturing, infrastructure construction, real estate construction and other industries. In 2020, the company’s SCB14 dry-type distribution transformer won the title of "Jiangsu Boutique" by China Quality Certification Center; The company’s SCB13-500/10 series dry-type transformers and other 18 models won the "High-tech Product Certification Certificate" from Jiangsu Science and Technology Department.

　　(Source: Straight Flush iFinD)

　　Baoshan iron & steel sent 1.8 yuan and date of record for every 10 shares in the first half of 2022 on October 12th.

　　Straight Flush Financial News baoshan iron & steel announced that the company’s half-year equity distribution implementation plan for 2022 is as follows: based on the total share capital of 22,156,577,300 shares, a cash dividend of 1.80 yuan will be distributed to all shareholders for every 10 shares, with a total cash dividend of 3.988 billion yuan, accounting for 51.19% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is on October 12th, and the ex-dividend date is on October 13th.

　　According to the 2022 semi-annual performance report released by baoshan iron & steel, the company’s operating income was 184.258 billion yuan, a year-on-year increase of 0.25%; The net profit attributable to shareholders of listed companies was 7.791 billion yuan, a year-on-year decrease of 48.36%; The basic earnings per share was 0.35 yuan, compared with 0.68 yuan in the same period last year.

　　Baoshan Iron and Steel Co., Ltd. is a company specializing in the steel industry, and engaged in processing and distribution, chemical industry, information technology, finance and e-commerce related to the main steel industry. The main steel products are divided into three categories: carbon steel, stainless steel and special steel. It is the largest and most modern steel joint venture in China.

　　In 2019, two achievements, Waste Incineration and Dioxin Pollution Control Technology and Countermeasures in iron and steel smelting, and Key Technology and Application of Enhanced Heating in Metallurgical Kilns, won the second prize of National Science and Technology Progress Award.

　　Five achievements, such as the key technology of design and manufacture of complex hydroforming pipe fittings for automobiles and their industrial application, won the first prize of metallurgical science and technology progress. Another six achievements won the second and third prizes of metallurgical science and technology respectively.

　　(Source: Straight Flush iFinD)

　　Shareholders of Yue ‘an New Materials intend to reduce their holdings by no more than 5% in total.

　　Yue Anxin Materials announced that the shareholders of the company, Ruihe Investment, Ruizhi Investment and Ruilan Investment, intend to reduce their holdings of the company’s shares, with a total reduction of no more than 2.56 million shares, accounting for no more than 2.9962% of the company’s total share capital; Yu Yuanbao, the company’s shareholder and director, intends to reduce the company’s shares through block trading, with a total reduction of no more than 1.708 million shares, accounting for no more than 1.9990% of the company’s total share capital.

　　Shuangliang energy saving: the subsidiary signed a major procurement contract for polysilicon materials.

　　Shuangliang Energy Saving Announcement: Jiangsu Shuangliang Silicon Material Technology Co., Ltd., a subsidiary, signed the Polycrystalline Silicon Sales Framework Contract with Shanghai east hope Energy Holding Co., Ltd., which stipulated that the company is expected to purchase 66,800 tons of polycrystalline silicon from east hope Energy Holding from 2022 to 2026, and the estimated purchase amount is about 20.24 billion yuan (including tax, this estimated price does not constitute a price commitment).

　　Ruichuang Micro-nano: The application for issuing convertible bonds was reviewed and approved by the Shanghai Municipal Committee of Shanghai Stock Exchange.

　　Ruichuang Micro-nano announced that the science and technology innovation board Listing Committee of the Shanghai Stock Exchange reviewed the company’s application for issuing convertible corporate bonds to unspecified objects, and the company’s application for issuing convertible corporate bonds to unspecified objects met the issuance conditions, listing conditions and information disclosure requirements.

　　Yue’ an New Materials: Shareholders intend to reduce the company’s shares by no more than 5%.

　　Yue Anxin Materials announced on the evening of September 29th that Yu Yuanbao, a shareholder and director of the company, intends to reduce the company’s shares by no more than 1.708 million shares through block trading, accounting for no more than 1.9990% of the company’s total share capital. The shareholders of the company, Ruihe Investment, Ruizhi Investment and Ruilan Investment, intend to reduce their holdings of the company’s shares by centralized bidding and block trading, with a total of no more than 2.56 million shares, accounting for no more than 2.9962% of the company’s total share capital. Ruihe Investment, Ruizhi Investment and Ruilan Investment constitute a concerted action.

　　Shandong glass fiber plans to sell 100 kg rhodium powder at the right opportunity.

　　Shandong Glass Fiber announced that in recent years, the technology of reducing rhodium bushing has gradually matured, and the amount of rhodium powder has gradually decreased. In order to revitalize the existing assets, the company plans to sell precious metal rhodium powder in the second half of 2022, and plans to sell 100 kilograms of rhodium powder at the right time.

　　Zhuhai Tuohong, the shareholder of Chenghe Technology, has reduced its shareholding by 1.5%, and the implementation has been completed.

　　Chenghe Technology announced that the company recently received the Letter of Notice on the Result of Reducing Shares of Chenghe Technology Co., Ltd. from Zhuhai Tuohong, a shareholder. Zhuhai Tuohong reduced its shares by 2 million shares through block transactions and centralized bidding transactions, accounting for 1.5% of the company’s total share capital. As of the announcement date, this reduction plan has been implemented.

　　Bright Real Estate intends to carry out the supply chain asset support plan business, and the shelf amount does not exceed 3 billion yuan.

　　() Announcement, in order to improve the cash flow of enterprises, the company intends to carry out the supply chain asset support plan business, that is, the upstream suppliers have the right to claim payment from the company or its subsidiaries within the scope of consolidated statements after fulfilling their obligations to sell goods or provide services; The supplier carries out factoring financing to the factoring company through the accounts receivable, thus forming the factoring creditor’s rights of the factoring company. The factoring company takes its accounts receivable from the company or subsidiaries within the scope of the company’s consolidated statements as the basic assets, and applies to China Insurance Assets Registration and Trading System Co., Ltd. ("China Insurance") for a shelf quota of no more than RMB 3 billion, and the company joins the debt as a joint debtor.

　　Yingjia Group plans to buy back 14.96 million shares and still holds Yingjia Distillery.

　　On September 29th, () announced that Yingjia Group, the controlling shareholder, planned to buy back 14.96 million shares and reduce its registered capital, which did not affect its controlling shareholder status.

　　According to the announcement, Yingjia Group has held a general meeting of shareholders and decided to buy back 14.96 million shares of Yingjia Group and reduce the registered capital, which is planned to be reduced from 243 million yuan to 228 million yuan.

　　Yingjia Group currently holds 74.66% of Yingjia Distillery. Yingjia Gongjiu said that the above changes do not involve changes in the rights and interests of the controlling shareholder Yingjia Group, and will not affect its controlling shareholder status. Ni Yongpei, the actual controller of the company, and his immediate family members passively increased the share of Yingjia Group from 39.22% to 41.79%, and the actual controller of the company did not change.

　　Top Group: It is planned to set up a subsidiary in Mexico and invest in the factory with no more than US$ 200 million.

　　Top Group announced that the company plans to set up a wholly-owned subsidiary "Top Group Mexico Co., Ltd." in Mexico and invest to build a factory, mainly producing lightweight chassis, interior systems, thermal management systems and robot actuators, with an estimated total investment of no more than 200 million US dollars.

　　Shuijingfang Qionglai Investment Project signed an investment agreement.

　　() It was announced on September 29th that it had signed the Investment Agreement of Shuijingfang Qionglai Industrial Chain Base Project (Phase II) with the government of Qionglai, Sichuan Province.

　　According to previously published information, Shuijingfang Qionglai Industrial Chain Base Project (Phase II) covers an area of about 735 mu, with an estimated total investment of about 4.048 billion yuan. The main contents of the project construction include brewing base, bottled wine packaging center, warehousing and logistics base, national laboratory, new product research and development center, koji-making workshop, base wine storage center and so on. After the completion of the project, it is estimated that the production capacity of Daqu medicine, brewing, tank farm, pottery jar and packaging workshop will be 35,000 tons/year, 13,000 tons/year, 64,000 tons/year, 52,700 tons/year respectively.

　　Shuijingfang once said that the implementation of the Qionglai full industrial chain base project (Phase II) is because the company’s liquor sales are in a steady development stage, and it is necessary to establish the second phase of the full industrial chain base in Qionglai to cooperate with the previous first phase project, establish a unified supply center, and integrate the entire manufacturing business into one site; Promote the adjustment of product structure, increase the output of high-end solid-state brewing liquor, support the high-quality raw liquor reserve of high-end liquor products of the company, and further improve the overall quality of liquor products.

　　Eurasia Group intends to use 100% equity of Eurasia North Lake Business to pledge the 20-year use right of Shengshi City Property.

　　() Announcement: On September 27, 2022, Changchun Eurasia Store Co., Ltd. ("Eurasia Store"), a holding subsidiary of the company, signed the Agreement with Jilin Shengshi Real Estate Development Co., Ltd. ("Shengshi Real Estate"), and both parties decided through consultation that the 100% equity of Changchun Eurasia Beihu Trading Co., Ltd. ("Eurasia Beihu Trading") held by Eurasia Store and the 20-year right to use Shengshi City Property owned by Shengshi Real Estate will be used as the right. The essence of this matter is that Eurasia Store leases the property of Shengshi City, and pays the rent with the equity of Eurasia North Lake. At the same time, Eurasia Store and Changchun Eurasia New Life Shopping Plaza Co., Ltd. ("Eurasia New Life") jointly operate the property of Shengshi City.

　　The announcement shows that the actual controller of Shengshi Real Estate is Longxiang Group (state-owned enterprise). Longxiang Group, with a registered capital of 6.604 billion yuan, is an important infrastructure construction entity and state-owned capital investment operation platform in Changchun New Area, and its business involves key projects such as infrastructure construction, shantytown renovation and asset management and maintenance in Changchun New Area.

　　Methylprednisolone succinate API of Tianyao Co., Ltd. obtained CEP certificate.

　　Tianyao Co., Ltd. announced on the evening of September 29 that the company had received the European Pharmacopoeia Applicability Certificate (CEP Certificate) issued by the European Drug Quality Administration for methylprednisolone succinate. This is also the second API under Tianyao Co., Ltd. to obtain CEP certificate this year. Previously, Fluoxetine API obtained CEP certificate in March.

　　Tianyao Co., Ltd. said that the company’s raw material drug methylprednisolone succinate has obtained CEP certificate, which indicates that the raw material drug meets the quality requirements of the European Pharmacopoeia, shows that the quality of the raw material drug is recognized and affirmed by the European standardized market, and indicates that the raw material drug can be sold in the European market and other standardized markets that recognize CEP certificate, which has a positive impact on the company’s further expansion of the international market.

　　It is understood that methylprednisolone succinate belongs to glucocorticoid drugs and is mainly used for anti-inflammatory treatment, such as rheumatic diseases, collagen diseases, skin diseases, allergic States, eye diseases, gastrointestinal diseases, respiratory diseases and edema States; Immunosuppression therapy (organ transplantation, blood diseases, tumors), treatment of shock, etc. According to the PDB database, the global market sales of methylprednisolone series preparations in 2020 and 2021 were US$ 870 million and US$ 960 million, respectively, and the corresponding raw material drug consumption was 31.4 tons and 36.6 tons respectively.

　　In addition to methylprednisolone succinate raw materials, the methylprednisolone sodium succinate preparation for injection produced by Jinyao Pharmaceutical Co., Ltd. obtained the ANDA approval number of American generic drug application in 2021, and passed the consistency evaluation of generic drug quality and efficacy. In July this year, methylprednisolone sodium succinate for injection was selected as the seventh batch of national centralized drug procurement, which will further promote the development of the company’s preparation business.

　　In fact, in recent years, Tianyao Co., Ltd. has been actively exploring the European and American markets, and has obvious advantages. Its corticosteroid bulk drug products such as prednisone, spironolactone, dexamethasone, methylprednisolone and methylprednisolone succinate have passed the FDA certification. In September last year, Valine API under Tianyao Co., Ltd. obtained the company’s first CEP certificate of amino acid products, which achieved a zero breakthrough in the company’s amino acid products entering the mainstream market in developed countries. Since then, betamethasone, fluoxetine and methylprednisolone succinate have successively obtained CEP certificates. Up to now, Tianyao Co., Ltd. has owned CEP certificates for more than ten products, and the international strategic layout has achieved remarkable results. (Hu Yan)

　　Ten favorable announcements on September 30th: Salt Lake Company plans to spend 750 million to 1.5 billion yuan to buy back its shares.

　　Salt Lake shares plan to spend 750 million to 1.5 billion yuan to buy back shares.

　　() Announcement, the company intends to use its own funds to buy back the company’s shares in a centralized bidding transaction, which will be used for the equity incentive plan or employee stock ownership plan. The total amount of repurchase funds is 750 million yuan-1.5 billion yuan, and the repurchase price does not exceed 40.62 yuan/share.

　　Wanhua Chemical: Increase MDI price in China in October.

　　Wanhua Chemical announced that since October 2022, the listing price of polymeric MDI in China area of the company is 19,800 yuan/ton (up 2,300 yuan/ton from September); The listing price of pure MDI is 23,000 yuan/ton (2,000 yuan/ton higher than that in September).

　　Jizhong Energy’s net profit increased by 174.34%-192.63% in the first three quarters.

　　() Disclosure of performance forecast for the first three quarters. The company expects to make a profit of RMB 3.75 billion to RMB 4 billion in the first three quarters of 2022, an increase of 174.34%-192.63% over the same period of last year. During the reporting period, the coal price was still at a high level. The company continued to implement the clean coal strategy and scientifically organize coal production, and the scale benefits continued to be released, and its performance steadily increased.

　　Jianyou shares: Micafenone for injection has been registered and approved by the US FDA.

　　Jianyou Co., Ltd. announced that the company recently received the approval letters of micafungin for injection, 50mg/ bottle and 100mg/ bottle issued by the US Food and Drug Administration ("FDA"). The indications of this drug are candidemia, acute disseminated candidiasis, candidal peritonitis and abscess, esophageal candidiasis, and prevention of candidal infection in patients undergoing hematopoietic stem cell transplantation (HSCT).

　　Chuanjinnuo’s net profit increased by 169.94%-199.93% in the first three quarters.

　　() Disclosure of performance forecast for the first three quarters. The company expects to make a profit of RMB 270 million-RMB 300 million in the first three quarters of 2022, an increase of 169.94%-199.93% over the same period of last year. During the reporting period, the company actively expanded its domestic and overseas markets. At the same time, with the commissioning of the fundraising project in Guangxi, the company’s operating income and operating profit have achieved rapid growth.

　　Ningbo Energy: The subsidiary plans to build Bowei comprehensive smart energy project.

　　Ningbo Energy announced that Langchen New Energy, a wholly-owned subsidiary, plans to set up a wholly-owned subsidiary Xiangshan Langchen Smart Energy Construction Bowei Comprehensive Smart Energy Project. The registered capital of the project company is 23 million yuan. The total investment of Bowei comprehensive smart energy project is 75,921,400 yuan. The scale of the project is to build two 5MW wind turbines with a total installed capacity of 10MW, and at the same time, it is equipped with a 1.7MW/3.4MWh Ferrous lithium phosphate energy storage system and four AC charging piles, and a comprehensive intelligent energy management and control platform system is also set up. The construction period of the project is expected to be 6 months and the operation period is 20 years. After the project is completed and put into operation, it is planned to adopt the business model of "spontaneous self-use and surplus online".

　　On the same day, the company announced that in order to promote Fenghua Pumped Storage Project, the company plans to form a joint venture with () East China Survey and Design Institute Co., Ltd., Ningbo Fenghua Xikou Urban Construction Investment Co., Ltd., Ningbo Fenghua Xikou Tourism Investment Co., Ltd. and Huichen Fund to form the Champion’s Ao Pumping Storage Company. The registered capital of the company is 150 million yuan, of which the company contributed 39 million yuan, with a shareholding ratio of 26%.

　　Dahua Co., Ltd.: The retail car of the shareholding company is listed on the Hong Kong Stock Exchange.

　　() Announcement: Zhejiang Zero Run Technology Co., Ltd., the company’s shareholding company, was listed on the main board of the Hong Kong Stock Exchange on September 29, 2022 with the stock code "09863". As of the announcement date, the company holds 90,000,000 shares of Zero Run Automobile, accounting for 7.88% of its total share capital after the issuance (excluding the factor of over-allotment option).

　　Yuntianhua: signed an agreement with Huayou Holdings on the cooperation intention of iron phosphate and Ferrous lithium phosphate projects.

　　Yuntianhua announced that the company and Huayou Holdings signed the Agreement on Intention of Cooperation on Iron Phosphate and Ferrous lithium phosphate Projects. The two sides intend to build a more complete and competitive industrial ecological chain through industrial cooperation between iron phosphate and Ferrous lithium phosphate, and promote the construction and operation of the 500,000-ton/year iron phosphate project and the 500,000-ton/year Ferrous lithium phosphate project.

　　Mingpu Optics and Magnetics plans to raise no more than 455 million yuan.

　　() Disclosure of the plan for non-public offering of shares. The total amount of funds raised in this issuance does not exceed 455 million yuan. After deducting the issuance expenses, the net amount of funds raised will be used for intelligent manufacturing projects of photovoltaic energy storage and chip communication magnetic components, industrial construction projects of vehicle-mounted BMS transformers, intelligent manufacturing projects of safe and intelligent optical storage systems and supplementary working capital.

　　Three Gorges Energy: 3.4 billion yuan is planned to participate in Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd.

　　Three Gorges Energy announced that the company plans to jointly invest with Yangtze Power, Three Gorges Capital and Three Gorges Investment to establish Inner Mongolia Three Gorges Onshore New Energy Investment Co., Ltd. to comprehensively carry out the acquisition, development and construction of new energy resources, with a registered capital of 10 billion yuan. Three Gorges Energy, Yangtze Power, Three Gorges Capital and Three Gorges Investment respectively subscribed 3.4 billion yuan, 3.3 billion yuan, 1.65 billion yuan and 1.65 billion yuan in cash, accounting for 34% of the registered capital of onshore investment companies respectively. Three Gorges Group is the controlling shareholder of the company, Yangtze Power and Three Gorges Capital are the holding subsidiaries of Three Gorges Group, and Three Gorges Investment is a wholly-owned subsidiary of Three Gorges Group.

　　Over 40 billion yuan! TBEA signed a sales order for 150,000 tons of polysilicon.

　　On September 29th, TBEA announced that the Company’s holding subsidiary Xinte Energy Co., Ltd. and its holding subsidiaries Xinjiang Xinte Crystal Silicon High-tech Co., Ltd., Inner Mongolia Xinte Silicon Materials Co., Ltd., wholly-owned subsidiary Xinte Silicon New Materials Co., Ltd. (hereinafter referred to as Xinte Energy Company) and Shuangliang Silicon Materials (Baotou) Co., Ltd. (hereinafter referred to as Shuangliang Silicon Materials Company) signed the Agreement on Strategic Cooperation in the Purchase and Sale of Polycrystalline Silicon, and Shuangliang Silicon Materials Company will sign the Agreement in January 2023.

　　According to the latest average price of 303,000 yuan/ton (including tax) published by PV InfoLink (September 28th, 2022), the estimated total sales amount is about 40.221 billion yuan (excluding tax, this estimated price does not constitute a price commitment). The actual sales price is negotiated with reference to the current market price, and the monthly Contract Execution Confirmation Sheet shall prevail.

　　China CNOOC will distribute 6.0844 yuan for every 10 shares in the first half of 2022, and date of record will be October 12th.

　　Straight Flush Financial News China CNOOC announced that the company’s half-year equity distribution implementation plan for 2022 is as follows: based on the total share capital of 2,990,000,000 shares, a cash dividend of 6.08 yuan will be distributed to all shareholders for every 10 shares, with a total cash dividend of 1.819 billion yuan, accounting for 2.53% of the net profit attributable to the mother in the same period. No bonus shares will be distributed, and no capital reserve will be converted into share capital.

　　The distribution of rights and interests in date of record is on October 12th, and the ex-dividend date is on October 13th.

　　According to the 2022 semi-annual performance report released by China CNOOC, the company’s operating income was 202.355 billion yuan, up 83.57% year-on-year; The net profit attributable to shareholders of listed companies was 71.887 billion yuan, a year-on-year increase of 115.69%; The basic earnings per share was 1.57 yuan, compared with 0.75 yuan in the same period last year.

　　China National Offshore Oil Co., Ltd. is a Hong Kong investment holding company established on August 20, 1999, mainly engaged in oil and gas exploration, production and trade. Its business includes conventional oil and gas business, shale oil and gas business, oil sands business and other unconventional oil and gas business. The company mainly operates through three branches. The exploration and production division is engaged in the exploration, development and production of crude oil, natural gas and other petroleum products. The trade branch is engaged in the trade of crude oil, natural gas and other petroleum products. The company’s branches are engaged in group-related businesses. The company mainly conducts business in China, Canada, UK, Nigerian, Indonesian and Brazilian markets.

　　(Source: Straight Flush iFinD)

　　The API of Tianyao Co., Ltd. was awarded CEP certificate to further expand the international market.

　　Tianyao Co., Ltd. announced on the evening of September 29 that the company had received the European Pharmacopoeia Applicability Certificate (CEP Certificate) issued by the European Drug Quality Administration for methylprednisolone succinate. This is also the second API under Tianyao Co., Ltd. to obtain CEP certificate this year. Previously, Fluoxetine API obtained CEP certificate in March.

　　Tianyao Co., Ltd. said that the company’s raw material drug methylprednisolone succinate has obtained CEP certificate, which shows that the raw material drug meets the quality requirements of the European Pharmacopoeia, shows the recognition and affirmation of the quality of the raw material drug in the European standardized market, and indicates that the raw material drug can be sold in the European market and other standardized markets that recognize CEP certificate, which has a positive impact on the company’s further expansion of the international market.

　　It is understood that methylprednisolone succinate belongs to glucocorticoid drugs and is mainly used for anti-inflammatory treatment, such as rheumatic diseases, collagen diseases, skin diseases, allergic States, eye diseases, gastrointestinal diseases, respiratory diseases and edema States; Immunosuppression therapy (organ transplantation, blood diseases, tumors), treatment of shock, etc. At present, methylprednisolone and methylprednisolone succinate are widely used hormone drugs, which are widely used in clinic and can be used to treat critical diseases with high efficiency, safety and good tolerance. According to the PDB database, the global market sales of methylprednisolone series preparations in 2020 and 2021 were US$ 870 million and US$ 960 million, respectively, and the corresponding raw material drug consumption was 31.4 tons and 36.6 tons respectively.

　　In addition to methylprednisolone succinate raw materials, the methylprednisolone sodium succinate preparation for injection produced by Jinyao Pharmaceutical Co., Ltd. obtained the ANDA approval number of American generic drug application in 2021, and passed the consistency evaluation of generic drug quality and efficacy. In July this year, methylprednisolone sodium succinate for injection was selected for the seventh batch of national centralized drug procurement, which will further promote the development of the company’s preparation business and have a positive impact on the company’s future business performance.

　　In fact, in recent years, Tianyao Co., Ltd. has been actively exploring the high-end markets in Europe and the United States, and its corticosteroid bulk drug products such as prednisone, spironolactone, dexamethasone, methylprednisolone succinate have already passed the FDA certification. In September last year, Valine API under Tianyao Co., Ltd. obtained the company’s first CEP certificate of amino acid products, achieving a zero breakthrough in the company’s amino acid products entering the mainstream market in developed countries. Since then, betamethasone, fluoxetine and methylprednisolone succinate have successively obtained CEP certificates. Up to now, Tianyao Co., Ltd. has owned CEP certificates for more than ten products, and the international strategic layout has achieved remarkable results, and the incremental space of the international high-end market will be further opened.

　　Bank of Hangzhou: Financial bonds (Phase I) in 2022 and Tier 2 capital bonds in 2022 were issued.

　　() On the evening of September 29th, it was announced that the company recently successfully issued "Hangzhou Bank Co., Ltd. 2022 Financial Bond (Phase I)" (hereinafter referred to as "22 Hangzhou Bank Bond 01") and "Hangzhou Bank Co., Ltd. 2022 Tier 2 Capital Bond" (hereinafter referred to as "22 Hangzhou Bank Tier 2 Capital Bond 01") in the national inter-bank bond market.

　　Among them, 22 Hangzhou Bank Bond 01 was recorded and filed on September 28th, and was issued on September 29th. The issuance scale was 15 billion yuan, and the variety was 3-year fixed-rate bonds, with coupon rate accounting for 2.50%. The funds raised in this bond will be used to optimize the matching structure of medium and long-term assets and liabilities, increase stable sources of medium and long-term liabilities and support the development of new medium and long-term assets business according to the approval of laws and regulatory authorities.

　　On September 28th, 2001, the secondary capital bond of Hangzhou Bank was recorded and filed, and it was issued on September 29th. The issuance scale was 10 billion yuan, and the variety was a 10-year fixed-rate bond. At the end of the fifth year, the issuer’s redemption right with preconditions was 3.15% in coupon rate. The funds raised in this bond will be used to supplement the company’s Tier 2 capital and support the sustained and steady development of the business according to the approval of laws and regulatory authorities.

　　ST Rongtai’s new management team strengthens compliance management and takes many measures to resolve risks.

　　On September 29th, ST Rongtai issued a progress announcement on the transfer of 100% equity of a wholly-owned subsidiary. Prior to this, the Company had held the fourth and fifth extraordinary shareholders’ meetings in succession, and passed the proposals on revising the Management System of External Guarantee, formulating the Management Measures for Preventing the Controlling Shareholders or Actual Controllers and Their Related Parties from Taking up Funds, formulating the Code of Conduct for Controlling Shareholders and Actual Controllers and transferring 100% equity of wholly-owned subsidiaries.

　　Since the new management team took office in May this year, on the one hand, it has optimized the internal control system, strengthened compliance management, and urged shareholders to return the occupied funds. As of June 27, 2022, the controlling shareholders and their related parties have returned the funds occupied by listed companies totaling 328,431,400 yuan, and all the non-operating funds occupied by the controlling shareholders and their related parties have been returned.

　　On the other hand, we should take measures to solve the problems left over from history and resolve risks, so as to promote the company to step into the right track. Including the revision of the company’s rules and regulations and timely disclosure, comprehensively combing all kinds of information that should be covered, such as account freezing, asset seizure, debt litigation, etc.

　　At the same time, actively resolve debt disputes. The company actively communicates with the court and creditors, fully understands the creditors’ thoughts and demands, negotiates with creditors as soon as possible, and strives to reach an agreement on the debt solution, jointly solve the debt problem and lift the frozen state of bank accounts. Since May 20th, ST Rongtai has reached a debt settlement with financial machine buyers and suppliers such as Hebei Bank, Guangfa Financial Leasing, Jinwo Leasing and Guangzhou Tianhe Agricultural Materials, and paid the corresponding settlement fees.

　　Make a scientific production and operation plan. The company will dispose of more than 1,000 acres of idle land and related assets, actively communicate and obtain the understanding of relevant creditors such as financial institutions, prevent the debt crisis, and improve the company’s ability to resist risks. In the future, the company plans to gradually and orderly withdraw from the investment and operation of the chemical sector while stabilizing the existing chemical business operation capability. At the same time, combined with the strategic deployment of the country’s "East Counting and West Counting", ST Rongtai plans to tilt resources such as funds and manpower to the Internet service sector. (Pan Jian)

　　Yingjia Gongjiu intends to reduce its registered capital.

　　On September 29th, Anhui Yingjia Distillery Co., Ltd. (hereinafter referred to as "Yingjia Distillery") issued a suggestive announcement about the controlling shareholder’s intention to reduce the registered capital. According to the announcement, Anhui Yingjia Group Co., Ltd. (hereinafter referred to as "Yingjia Group"), the controlling shareholder of Yingjia Distillery, decided to buy back 14,960,000 shares of Yingjia Group and reduce its registered capital. The registered capital of Yingjia Group is planned to be reduced from 243,561,996 yuan to 228,601,996 yuan.

　　Yingjia Distillery pointed out that the capital reduction behavior of Yingjia Group will not affect its controlling shareholder status. The proportion of shares held by Ni Yongpei and his immediate family has passively increased from 39.22% to 41.79%, and the actual controller of the company has not changed.